BOC Sciences is a long-standing supplier of reagents and service solutions for chemical and biosynthetic research. We have supported research teams and companies across multiple countries and regions in drug development, fine chemicals, and materials science. With strong expertise in chiral synthesis, a professional team of synthetic chemists, and standardized synthesis laboratories, we provide a broad portfolio of ready-to-use chiral catalyst products, as well as custom synthesis and screening services for project-specific chiral catalyst development.
Chiral catalysts are catalysts with inherent chiral structures, such as chiral centers, chiral axes, or chiral planes. They guide reactions by forming diastereomeric transition states with substrates and selectively recognizing one prochiral face of the substrate through the steric effects and weak interactions of the chiral microenvironment, such as hydrogen bonding and π-π stacking, thereby preferentially generating a single enantiomeric product. Their basic structure typically consists of a chiral ligand, such as BINAP or proline derivatives, and a catalytically active center, such as a transition metal or organic functional group. In a reaction, only a catalytic amount of the chiral catalyst, usually 0.01–10 mol%, is required to achieve efficient chiral induction, lower the activation energy, and control the stereochemical pathway, enabling racemic or achiral substrates to be converted into chiral products with high selectivity. Chiral catalysts are suitable for asymmetric hydrogenation, C-C bond formation, redox reactions, and other transformations, serving applications in the pharmaceutical industry, such as chiral drug intermediates, fine chemicals, including agrochemicals and fragrances, and academic research where highly enantioselective construction of chiral molecules, such as ee >90%, is required.
Our team supports the custom synthesis and screening of chiral transition metal catalysts, including chiral phosphine-rhodium complexes, bisoxazoline-copper catalysts, salen-metal systems, and other ligand-coordinated catalytic complexes. These chiral catalysts use a coordinated metal center as the active catalytic site, while the surrounding chiral ligand environment controls substrate orientation and stereochemical outcome. They are suitable for asymmetric hydrogenation, C-C bond formation, cyclization, allylation, and other stereoselective transformations used in the preparation of chiral pharmaceutical intermediates, fine chemicals, and specialty molecules.
For enzyme-driven asymmetric synthesis, we develop custom expression, preparation, and screening workflows for chiral biocatalysts, including lipases, ketoreductases, transaminases, hydrolases, oxidases, and related engineered enzymes. These catalysts rely on the three-dimensional protein structure to recognize prochiral or chiral substrates and guide stereoselective conversion. They are suitable for asymmetric reduction, hydrolysis, transamination, kinetic resolution, and other mild-condition transformations, supporting greener synthesis strategies for high-value chiral compounds and advanced intermediates.
In metal-free asymmetric catalysis projects, our chemists design, synthesize, and screen chiral small-molecule organocatalysts such as proline derivatives, chiral thioureas, squaramides, chiral phosphoric acids, imidazolidinones, and cinchona alkaloid-derived catalysts. These chiral catalysts activate substrates through hydrogen bonding, covalent activation, ion-pair interaction, or bifunctional recognition. They are widely used in aldol reactions, Michael additions, Mannich reactions, Diels-Alder reactions, and other asymmetric transformations for academic research, early drug discovery, and chiral building block construction.
For recyclable and process-oriented catalytic systems, we construct magnetically recoverable chiral catalysts based on Fe3O4 magnetic nanoparticles functionalized with chiral ligands, chiral metal complexes, or chiral organocatalytic groups. These supported chiral nanocatalysts combine stereoselective catalytic activity with magnetic responsiveness, enabling convenient catalyst separation, recovery, and reuse. They are especially useful for continuous-flow reaction evaluation, recyclable catalyst development, reduced catalyst-related residue concerns, and process-oriented asymmetric synthesis workflows.
BOC Sciences helps research teams move from substrate evaluation to catalyst selection, reaction screening, stereochemical confirmation, purification, and application-ready chiral intermediates.
We provide customized chiral catalyst synthesis, catalyst screening, catalytic reaction development, product separation, and stereochemical confirmation services for research teams that need efficient asymmetric transformation and practical access to stereodefined molecules. Key categories include:
| Service Segment | Description | Representative Systems |
| Transition Metal Chiral Catalysts | Formation of catalytically active centers through coordination between chiral ligands and transition metals | Chiral phosphine-rhodium catalysts, such as BINAP-Rh; chiral bisoxazoline-copper catalysts, such as Box-Cu; chiral diamine-ruthenium catalysts, such as TsDPEN-Ru |
| Small-Molecule Chiral Organocatalysts | Metal-free catalysis using chiral organic molecules | Proline derivatives, chiral thioureas, cinchona alkaloids, chiral phosphoric acids |
| Enzymes / Biocatalysts | Asymmetric transformations catalyzed by natural or engineered enzymes | Lipases, transaminases, ketoreductases, monooxygenases |
| Chiral Phase-Transfer Catalysts | Two-phase reaction promotion using chiral quaternary ammonium salts or crown ethers | Chiral benzyl quaternary ammonium salts, chiral crown ethers |
| Chiral Lewis Acid Catalysts | Coordination of chiral ligands with Lewis acidic metals | Chiral aluminum complexes, chiral titanium complexes |
| Chiral Brønsted Acid Catalysts | Catalysis driven by chiral proton acids | Chiral phosphoric acids, CPAs; chiral sulfonamides |
| Chiral Photocatalysts | Asymmetric photoreactions driven by chiral photosensitizers | Chiral iridium/ruthenium complexes, chiral organic dyes |
| Chiral NHC Catalysts | Catalysis using chiral N-heterocyclic carbenes | Chiral imidazolium salts, chiral triazolium salts |
| Chiral Bifunctional Catalysts | Catalysts with combined Lewis acid/base functions or hydrogen-bond donor/acceptor functions | Chiral thiourea-amines, chiral squaramides |
| Immobilized Chiral Catalysts | Homogeneous chiral catalysts immobilized onto solid supports | Polymer-supported BINAP, MOF-supported chiral ligands |
Share your target structure, desired stereochemical outcome, substrate class, known reaction bottleneck, expected transformation, catalyst preference, analytical requirements, and quantity need. Our specialists will design a project-specific plan covering catalyst choice, reaction types, catalyst loading, condition screening, product isolation, and stereochemical confirmation.
We communicate in depth with the client about the target reaction type, substrate structure, expected ee value, and yield indicators. A customized technical proposal is provided, clarifying catalyst scaffold recommendations, project cycle, and delivery standards.
Candidate catalysts are rapidly evaluated for activity and enantioselectivity through a high-throughput screening platform. The optimal catalyst system is identified, followed by structural confirmation and preliminary optimization of process parameters.
If needed, gram-scale to tens-of-grams scale-up verification is carried out to evaluate reproducibility and operational feasibility. Catalyst recovery strategies or continuous-flow processes are developed.
Catalyst structural characterization, including NMR and MS, performance evaluation, including ee value, and stability testing are completed. Catalyst samples, process reports, analytical data packages, and follow-up technical support plans are delivered.
A catalytic reaction can show excellent substrate consumption while delivering only modest enantiomeric enrichment. This often results from weak catalyst-substrate recognition, competing uncatalyzed background reaction, poor ligand geometry, or solvent-driven transition-state changes. BOC Sciences addresses this by comparing catalyst families, ligand structures, catalyst loading, additives, temperature profiles, and substrate concentration while tracking conversion and stereochemical outcome through orthogonal analytical methods.
Heteroatom-rich substrates, sulfur-containing motifs, amines, coordinating heterocycles, or polar functional groups may bind to the catalyst and suppress turnover. BOC Sciences evaluates protection strategy, additive choice, catalyst precursor form, ligand ratio, reagent order, and solvent polarity to reduce catalyst poisoning. For suitable projects, we also assess metal catalysis technology options that better tolerate the client's substrate features.
Catalyst-derived residues, ligand fragments, homocoupling by-products, over-reduced materials, or minor stereoisomers can complicate downstream synthesis. BOC Sciences supports these projects through solvent screening, crystallization assessment, flash chromatography, preparative HPLC, chiral analysis and separation, and product-focused cleanup workflows. We help clients decide whether purification, catalyst modification, or reaction redesign is the more practical route.
A catalyst may work for one substrate but fail when the client expands aryl, heteroaryl, alkyl, or functional group variants. BOC Sciences reviews the target series before route design, then evaluates catalyst generality, protecting group compatibility, functional-handle tolerance, and downstream conversion needs. This supports lead optimization, analog synthesis, and scaffold diversification rather than producing a single isolated proof-of-concept result.
Collaborate with BOC Sciences to access chiral catalysts, custom catalyst synthesis, catalyst-screening workflows, stereodefined intermediates, optimized asymmetric reaction conditions, and analytical data packages that help your team choose a practical catalytic route.
BOC Sciences is supported by experienced synthetic chemists, including PhD-level researchers with strong backgrounds in asymmetric catalysis, stereoselective route design, organocatalysis, metal-ligand chemistry, heterocyclic chemistry, and complex intermediate development.
Each project can combine catalyst selection, catalyst synthesis, substrate conversion studies, purification, chiral analysis, and analytical method development, helping clients move from an uncertain catalytic idea to a practical working route.
We do not evaluate catalysts as isolated reagents. Our team considers substrate scope, analog expansion, intermediate stability, downstream coupling, and intermediates synthesis requirements when designing each catalyst-guided workflow.
Our integrated platform supports organocatalysis, metal catalysis, biocatalytic technology, chromatography, NMR, LC-MS, chiral HPLC, continuous flow reaction technology, and other tools for reliable compound development.
Client Needs: A pharmaceutical research team needed a customized chiral metal catalyst for an asymmetric hydrogenation reaction involving a sterically hindered imine substrate. Commercial catalyst systems showed acceptable conversion but unstable enantioselectivity across different substrate batches.
Challenges: The substrate contained a coordinating heteroatom that interfered with metal-ligand activation. Several common Rh and Ru catalyst systems gave inconsistent reaction profiles, and the client needed a catalyst structure that could support further analog screening.
Solution: We designed a focused chiral phosphine-metal catalyst panel based on BINAP, SegPhos, and Josiphos scaffolds. Twelve ligand derivatives were synthesized or selected, then assembled with Rh and Ru precursors for parallel screening. LC-MS monitored conversion, while chiral HPLC compared ee values under different solvent, pressure, additive, and catalyst-loading conditions.
Outcome: The project identified a more suitable chiral metal catalyst system with improved stereochemical consistency and provided the client with catalyst structure, screening data, and reaction-condition recommendations for continued development.
Client Needs: A discovery chemistry group wanted to evaluate metal-free chiral organocatalysts for an asymmetric Michael addition used to construct a β-substituted carbonyl building block. The client required guidance on catalyst type, activation mode, and substrate compatibility.
Challenges: The reaction was sensitive to solvent polarity and base strength, while several initial catalysts produced side reactions or low ee values. The client also needed a screening strategy that could compare thiourea, squaramide, proline-derived, and cinchona-derived catalysts efficiently.
Solution: We built a small-molecule chiral organocatalyst screening workflow covering thiourea-amines, squaramides, proline derivatives, and cinchona alkaloid catalysts. Thirty-six microscale reactions evaluated catalyst structure, solvent, temperature, additive, and substrate ratio. Reaction progress was tracked by LC-MS and 1H NMR, followed by chiral HPLC analysis of selected conditions.
Outcome: The client received a prioritized organocatalyst shortlist, clear structure-performance comparison, and optimized starting conditions for further asymmetric reaction development.
Client Needs: A fine chemical research team required a recyclable chiral catalyst platform for repeated asymmetric addition experiments. The client was interested in magnetic catalyst recovery to simplify catalyst separation and reduce catalyst-related interference in downstream analysis.
Challenges: Direct immobilization reduced catalyst activity in early trials, and the linker length affected both substrate access and stereochemical control. The supported catalyst also needed stable magnetic separation behavior across repeated reaction cycles.
Solution: We prepared Fe3O4-supported chiral catalyst candidates using three linker designs and two chiral ligand systems. The materials were characterized by NMR-compatible ligand analysis, HRMS of ligand precursors, particle dispersion review, and magnetic separation testing. Catalytic activity, ee value, and reusability were evaluated across six reaction cycles.
Outcome: The project delivered a recyclable magnetic chiral catalyst prototype with comparative performance data, recovery behavior assessment, and recommendations for further support modification.
Selecting a suitable chiral catalyst requires more than matching a reaction name with a common catalyst class. Researchers need to consider substrate structure, desired absolute configuration, reaction mechanism, functional group tolerance, solvent system, catalyst loading, metal compatibility, and downstream scalability. BOC Sciences evaluates the client’s substrate, target product, previous experimental data, and stereochemical challenges to recommend candidate systems such as chiral phosphine ligands, chiral phosphoric acids, BINOL/SPINOL-derived catalysts, organocatalysts, and metal-ligand complexes. Small-scale screening and analytical feedback help identify catalysts with better conversion, enantioselectivity, and practical reaction behavior.
BOC Sciences supports a broad range of chiral catalyst products and development projects for asymmetric hydrogenation, asymmetric addition, oxidation, cyclization, C-C/C-X bond formation, chiral intermediate synthesis, and fine chemical development. Available support may include chiral phosphine ligands, chiral phosphoric acid catalysts, BINOL, H8-BINOL, SPINOL derivatives, chiral NHC ligands, small-molecule organocatalysts, metal-ligand complexes, and project-specific catalyst analogs. When catalog products are not sufficient, our team can combine product sourcing, custom synthesis, structural modification, and reaction testing to build a catalyst solution better matched to the client’s substrate and transformation target.
Chiral catalyst screening is not simply a matter of testing several catalyst names. A practical screening program should evaluate catalyst structure, ligand electronics, steric profile, metal source, additives, acid/base conditions, solvent, temperature, substrate concentration, and reagent ratio in a structured matrix. BOC Sciences designs screening workflows according to the target reaction type and monitors performance using HPLC, UPLC, LC-MS, GC, chiral chromatography, or other suitable analytical methods. By comparing conversion, ee, dr, by-product formation, and reaction robustness, we help clients determine whether to change catalyst families, optimize substituent patterns, or redesign substrate protection and activation strategies.
Yes. BOC Sciences provides custom synthesis support for chiral catalysts, ligands, and structural analogs that are difficult to obtain from standard product catalogs. Typical projects include modifying aryl substituents, tuning steric bulk, introducing electron-donating or electron-withdrawing groups, extending linker units, preparing chiral phosphoric acid derivatives, developing new chiral phosphine ligands, or building organocatalysts designed for specific substrate recognition. Our workflow may include route assessment, key chiral scaffold construction, functional group transformation, metal-complex preparation, purification, and structural confirmation. This approach is especially useful when existing catalysts show insufficient selectivity, poor conversion, or limited compatibility with complex substrates.
Chiral catalyst development, product supply, custom synthesis, and screening services are useful for pharmaceutical intermediates, chiral building blocks, fine chemicals, fragrance compounds, agrochemical intermediates, functional material monomers, and asymmetric synthesis route development. Clients often seek support when racemic resolution is inefficient, literature conditions are hard to reproduce, stereoselectivity is insufficient, or catalyst cost and availability limit further development. BOC Sciences provides an integrated workflow covering catalyst selection, product supply, reaction screening, structure modification, custom synthesis, and analytical confirmation, helping research teams identify more reliable asymmetric transformation conditions and generate stronger experimental evidence for future process optimization.
The chiral catalyst samples we received showed a clean analytical profile and performed consistently in our asymmetric reaction tests. The quality made it easier for our team to compare reaction outcomes without unnecessary interference from catalyst-related impurities.
— Davidson, Senior Synthetic Chemist
Our project required a modified chiral ligand-metal catalyst that was not suitable for direct catalog purchase. BOC Sciences understood the structure quickly, arranged custom synthesis efficiently, and helped us keep the catalyst evaluation work moving forward.
— Matthews, Medicinal Chemistry Project Lead
We needed several chiral catalysts for early screening but had to control research costs. Their team recommended a practical catalyst panel instead of an oversized screening list, giving us useful results with a more reasonable project budget.
— Leclerc, Fine Chemicals R&D Manager
At the beginning, we were unsure whether a metal catalyst, organocatalyst, or biocatalyst would be the best direction. BOC Sciences compared different chiral catalyst systems and helped us identify the most suitable option for our substrate and target stereochemistry.
— Hartley, Principal Scientist
If you have any questions or encounter issues on this page, please don't hesitate to reach out. Our support team is ready to assist you.
